Navigation Links
Fair trade
Date:6/16/2008

This release is available in German.

Because of its toxicity and the dangers involved in handling it, tetrachloromethane (carbon tetrachloride, CCl4) can no longer be used or produced in many countries. However, the processes used in the production of other chlorinated hydrocarbons, such as chloroform (trichloromethane, CHCl3), also produce CCl4 as a byproduct. What is the best way to get rid of this unwanted substance? A team headed by Bert M. Weckhuysen at the University of Utrecht (Netherlands) has now found an interesting new approach that may lead to effective recycling. As the researchers report in the journal Angewandte Chemie, a lanthanum chloride catalyst induces CCl4 and its reaction partner dichloromethane (CH2Cl2) to exchange one chlorine atom for a hydrogen atom, forming nearly 100 % of the desired CHCl3.

In order to increase the catalyst surface, lanthanum chloride (LaCl3) was deposited onto carbon nanofiber supports. This results in a highly active, selective, and stable catalyst to facilitate the hydrogenchlorine exchange between CCl4 and CH2Cl2. "Computer calculations suggest," says Weckhuysen, "that the mechanism occurs by way of two separate hydrogenchlorine exchange reactions." It appears that the surface of the LaCl3 catalyst contains not only the terminal chlorine atoms of the crystal lattice, but also other weakly adsorbed species. CH2Cl2 swaps one of its hydrogen atoms for one such weakly bound chlorine atom. It leaves behind the hydrogen atom, which is in turn weakly adsorbed to the catalyst surface. This hydrogen atom can be taken up by CCl4, which in turn leaves one of its chlorine atoms behind on the catalyst surface. Both of these reaction steps produce chloroform exclusively; no byproducts come into play.

This new catalytic reaction is astonishing in that it was previously assumed that the presence of oxygeneither in the gas phase or bound to the crystal lattice of the catalystis required for such reactions. Says Weckhuysen: "We are reporting for the first time a lanthanum-based catalyst material that can activate both C-H and C-Cl bonds in the absence of oxygen." (2193 characters)


'/>"/>

Contact: Bert M. Weckhuysen
b.m.weckhuysen@uu.nl
31-302-534-328
Wiley-Blackwell
Source:Eurekalert  

Related biology news :

1. Stinger Systems To Offer Taser Trade-In Program
2. Global trade in tiger shrimp threatens environment
3. Markets of biodiversity and equity in trade: An illusion?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fair trade
(Date:11/19/2016)... 18, 2016 Securus Technologies, a leading provider ... safety, investigation, corrections and monitoring, announced today that it ... to have an independent technology judge determine who has ... high tech/sophisticated telephone calling platform, and the best customer ... do most of what we do – which clearly ...
(Date:11/15/2016)... Research and Markets has announced the addition of the ... offering. ... The global bioinformatics market is ... Billion in 2016, growing at a CAGR of 21.1% during the ... driven by the growing demand for nucleic acid and protein sequencing, ...
(Date:6/22/2016)... 2016   Acuant , the leading ... has partnered with RightCrowd ® to ... Management, Self-Service Kiosks and Continuous Workforce Assurance. ... functional enhancements to existing physical access control ... with an automated ID verification and authentication ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... light to control cells — optogenetics — is key to exciting advances in ... the art, spatially patterned light projected via free-space optics stimulates small, transparent organisms ...
(Date:12/8/2016)... Mass (PRWEB) , ... December 08, 2016 , ... ... genetic data bioInformatics portal. In response to client demand KbioBox developed a sophisticated ... edit biodesign program. Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ ...
(Date:12/8/2016)... 8, 2016 Soligenix, Inc. (OTCQB: SNGX) (Soligenix ... developing and commercializing products to treat rare diseases where ... it will be hosting an Investor Webcast Event Friday, ... origins of innate defense regulators (IDRs) as a new ... mucositis and the recently announced and published Phase 2 ...
(Date:12/8/2016)... Dec. 8, 2016   Biocept, Inc . ... provider of clinically actionable liquid biopsy tests to ... clinical data featuring its Target Selector™ Circulating Tumor ... for the detection of actionable biomarkers in patients ... sponsored by Sara Cannon Research Institute (SCRI), the ...
Breaking Biology Technology: